Article: Down-regulation of stathmin is required for TGF-β inducible early gene 1 induced growth inhibition of pancreatic cancer cells
| Title | Down-regulation of stathmin is required for TGF-β inducible early gene 1 induced growth inhibition of pancreatic cancer cells |
|---|---|
| Authors | Jiang, L2 4 Chen, Y4 Chan, Cy4 Wang, X4 Lin, L3 He, Ml4 Lin, MCM1 Yew, DT4 Sung, JJY4 Li, JC2 Kung, Hf4 |
| Keywords | Apoptosis Chemosensitivity Pancreatic cancer Stathmin TIEG1 |
| Issue Date | 2009 |
| Publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/canlet |
| Citation | Cancer Letters, 2009, v. 274 n. 1, p. 101-108 [How to Cite?] DOI: http://dx.doi.org/10.1016/j.canlet.2008.09.017 |
| Abstract | Transforming growth factor-beta (TGF-β) inducible early gene 1 (TIEG1) is known to induce apoptosis in TGF-β sensitive pancreatic cancer cells, yet its effect on TGF-β resistant cancer cells remains unclear. In this study, TIEG1 was found to induce apoptosis in TGF-β resistant cancer cells and concurrently enhanced gemcitabine chemosensitivity. Down-regulation of stathmin was noted to associate with TIEG1 expression, whilst ectopic overexpression of stathmin prevented TIEG1 mediated growth inhibition of tumor cells. Small interfering RNAs targeting stathmin inhibited pancreatic cancer cell growth. These suggest that stathmin is a downstream target of TIEG1. © 2008 Elsevier Ireland Ltd. All rights reserved. |
| ISSN | 0304-3835 2011 Impact Factor: 4.238 2011 SCImago Journal Rankings: 0.494 |
| DOI | http://dx.doi.org/10.1016/j.canlet.2008.09.017 |
| References | References in Scopus |
| dc.contributor.author | Jiang, L | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| dc.contributor.author | Chen, Y | ||||||||||
| dc.contributor.author | Chan, Cy | ||||||||||
| dc.contributor.author | Wang, X | ||||||||||
| dc.contributor.author | Lin, L | ||||||||||
| dc.contributor.author | He, Ml | ||||||||||
| dc.contributor.author | Lin, MCM | ||||||||||
| dc.contributor.author | Yew, DT | ||||||||||
| dc.contributor.author | Sung, JJY | ||||||||||
| dc.contributor.author | Li, JC | ||||||||||
| dc.contributor.author | Kung, Hf | ||||||||||
| dc.date.accessioned | 2010-05-31T03:30:55Z | ||||||||||
| dc.date.available | 2010-05-31T03:30:55Z | ||||||||||
| dc.date.issued | 2009 | ||||||||||
| dc.description.abstract | Transforming growth factor-beta (TGF-β) inducible early gene 1 (TIEG1) is known to induce apoptosis in TGF-β sensitive pancreatic cancer cells, yet its effect on TGF-β resistant cancer cells remains unclear. In this study, TIEG1 was found to induce apoptosis in TGF-β resistant cancer cells and concurrently enhanced gemcitabine chemosensitivity. Down-regulation of stathmin was noted to associate with TIEG1 expression, whilst ectopic overexpression of stathmin prevented TIEG1 mediated growth inhibition of tumor cells. Small interfering RNAs targeting stathmin inhibited pancreatic cancer cell growth. These suggest that stathmin is a downstream target of TIEG1. © 2008 Elsevier Ireland Ltd. All rights reserved. | ||||||||||
| dc.description.nature | Link_to_subscribed_fulltext | ||||||||||
| dc.identifier.citation | Cancer Letters, 2009, v. 274 n. 1, p. 101-108 [How to Cite?] DOI: http://dx.doi.org/10.1016/j.canlet.2008.09.017 | ||||||||||
| dc.identifier.doi | http://dx.doi.org/10.1016/j.canlet.2008.09.017 | ||||||||||
| dc.identifier.epage | 108 | ||||||||||
| dc.identifier.hkuros | 153177 | ||||||||||
| dc.identifier.isi | WOS:000262735500014
Funding Information: This work was Supported by grants from Hong Kong Research Grant Council (CUHK7422/03M, 2140564 and 467507 to H.F.K.), Li Ka Shing Institute of Health Sciences to H.FK, the Foundation of Guangzhou Science and Technology Bureau (2005Z1-E0131 to H.F.K), and Direct Grants from the Chinese University of Hong Kong (2041270 and 2041345) to Y.C. | ||||||||||
| dc.identifier.issn | 0304-3835 2011 Impact Factor: 4.238 2011 SCImago Journal Rankings: 0.494 | ||||||||||
| dc.identifier.issue | 1 | ||||||||||
| dc.identifier.openurl | ![]() | ||||||||||
| dc.identifier.pmid | 18930345 | ||||||||||
| dc.identifier.scopus | eid_2-s2.0-57749084479 | ||||||||||
| dc.identifier.spage | 101 | ||||||||||
| dc.identifier.uri | http://hdl.handle.net/10722/58473 | ||||||||||
| dc.identifier.volume | 274 | ||||||||||
| dc.language | eng | ||||||||||
| dc.publisher | Elsevier Ireland Ltd. The Journal's web site is located at http://www.elsevier.com/locate/canlet | ||||||||||
| dc.publisher.place | Ireland | ||||||||||
| dc.relation.ispartof | Cancer Letters | ||||||||||
| dc.relation.references | References in Scopus | ||||||||||
| dc.rights | Cancer Letters. Copyright © Elsevier Ireland Ltd. | ||||||||||
| dc.subject | Apoptosis | ||||||||||
| dc.subject | Chemosensitivity | ||||||||||
| dc.subject | Pancreatic cancer | ||||||||||
| dc.subject | Stathmin | ||||||||||
| dc.subject | TIEG1 | ||||||||||
| dc.title | Down-regulation of stathmin is required for TGF-β inducible early gene 1 induced growth inhibition of pancreatic cancer cells | ||||||||||
| dc.type | Article |
Author Affiliations
- The University of Hong Kong
- Zhejiang University
- Hong Kong Polytechnic University
- Chinese University of Hong Kong


